Completed PHASE4 INTERVENTIONAL 3-arm NCT00646984

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Comparison of Strategies of Interruption/Reinitiation of Antiretroviral Therapy in Response to Immunologic/Virologic Changes in HIV-Infected Patients With Lipodystrophy.

Sponsor: Hospital Clinic of Barcelona

Conditions HIV-Associated Lipodystrophy Syndrome

Interventions CD-4 guided therapy interruption Standard continuous antiretroviral therapy Viral load driven treatment interruption

Updated 5 times since 2017 Last updated: Mar 28, 2008 Started: Jan 31, 2002 Primary completion: Apr 30, 2005 Completion: Apr 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on HIV-Associated Lipodystrophy Syndrome, this trial is completed. The trial is conducted by Hospital Clinic of Barcelona and has accumulated 5 data snapshots since 2002. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Clinic of Barcelona

Data source: Hospital Clinic of Barcelona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain